To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCT4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
523 supporting clones for gene CCT4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK303082 thymus .a 1 to 1934 2 to 1935 P5L K550R tiling clone,   1935/1935
(100 %)
3 diff
(99.9 %id)
DC404786 thymus .a 1 to 553 2 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DC344527 cervix .b 1 to 560 1 to 560   tiling clone,   560/560
(100 %)
1 diff
(99.9 %id)
DC313574 amygdala .b 3 to 549 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
FN107618 breast carcinoma .b 14 to 114 1 to 99       99/102
(97 %)
3 diff
(97.1 %id)
DB461009 testis .b 132 to 612 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
DC386345   .b 134 to 700 8 to 574       567/567
(100 %)
0 diff
(100 %id)
DC360445   .b 137 to 677 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC395206 testis .b 137 to 688 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
DC396547 testis .b 137 to 716 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DC398321 testis .b 137 to 689 1 to 553       553/553
(100 %)
0 diff
(100 %id)
TI_154177278   .b 147 to 567 201 to 624       424/866
(48 %)
17 diff
(98.1 %id)
BP271441 small intestine .b 149 to 731 1 to 583       583/583
(100 %)
0 diff
(100 %id)
NM_006430.2   .b 149 to 2481 1 to 2333 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2333/2333
(100 %)
0 diff
(100 %id)
DB201155 trachea .b 150 to 740 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
TI_154182829   .b 155 to 678 72 to 597       526/849
(61 %)
28 diff
(96.8 %id)
DB456107 testis .b 156 to 645 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
DB477539 hippocampus .b 156 to 644 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BC093446 Ovary, adenocarcinoma .b 162 to 2106 1 to 1946 T490N A491C G492R I493H N494* AAA   1946/6127
(31 %)
4 diff
(100.0 %id)
TI_45214425   .b 162 to 922 88 to 843       756/846
(89 %)
14 diff
(98.4 %id)
BQ645164 hepatocellular carcinoma, cell line, Liver .b 163 to 1069 1 to 907       907/908
(99 %)
10 diff
(98.9 %id)
BQ925564 epidermoid carcinoma, cell line, lung .b 163 to 1038 1 to 885       885/910
(97 %)
22 diff
(97.6 %id)
DA371572 thalamus .b 165 to 796 2 to 633   capped   632/632
(100 %)
0 diff
(100 %id)
DA383870 thalamus .b 165 to 801 2 to 638   capped   637/637
(100 %)
0 diff
(100 %id)
TI_45211170   .b 165 to 947 89 to 876       788/1067
(73 %)
26 diff
(97.6 %id)
BU859595 ovary, teratocarcinoma, cell line .b 166 to 930 1 to 775       775/950
(81 %)
13 diff
(98.7 %id)
BM152836 leukopheresis .b 166 to 594 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
AK290538 brain .b 167 to 2173 1 to 2007 K122R     2007/2007
(100 %)
3 diff
(99.9 %id)
BQ060683 lymph, lymphoma, cell line .b 167 to 1074 1 to 914       914/980
(93 %)
13 diff
(98.7 %id)
BQ066793 lymph, lymphoma, cell line .b 167 to 1074 1 to 920       920/1022
(90 %)
18 diff
(98.3 %id)
DA303516 hippocampus .b 168 to 761 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA536094 heart .b 168 to 755 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
AW163004 brain, frontal lobe .b 168 to 774 1 to 607       607/610
(99 %)
1 diff
(99.9 %id)
BJ992029 hepatoblastoma .b 171 to 583 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
TI_44348714   .b 171 to 861 129 to 821       691/951
(72 %)
16 diff
(98.4 %id)
BP227285   .b 172 to 752 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ059820 lymph, lymphoma, cell line .b 173 to 953 1 to 787       787/1074
(73 %)
19 diff
(98.3 %id)
BQ641933 lymph, lymphoma, cell line .b 173 to 942 1 to 771       771/996
(77 %)
30 diff
(97.0 %id)
BP267912 thyroid .b 173 to 753 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB463783 hippocampus .b 175 to 567 1 to 393       393/403
(97 %)
4 diff
(99.1 %id)
CR981210 T-Lymphocytes .b 178 to 1064 1 to 892       892/899
(99 %)
6 diff
(99.4 %id)
TI_45209221   .b 184 to 941 86 to 844       759/851
(89 %)
10 diff
(98.9 %id)
TI_45214768   .b 184 to 941 131 to 898       768/1008
(76 %)
25 diff
(97.6 %id)
DA078024 cerebellum .b 186 to 775 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA130023 alzheimer cortex .b 186 to 798 2 to 614   capped   613/613
(100 %)
0 diff
(100 %id)
DB504411 hypothalamus .b 186 to 658 1 to 473       473/473
(100 %)
0 diff
(100 %id)
TI_44344176   .b 186 to 918 88 to 818       731/818
(89 %)
9 diff
(98.9 %id)
AU124758   .b 186 to 1027 2 to 840   capped   837/839
(99 %)
9 diff
(99.0 %id)
AU124605   .b 187 to 1028 2 to 845   capped   842/844
(99 %)
6 diff
(99.3 %id)
AU126238   .b 187 to 941 2 to 755   capped   754/768
(98 %)
5 diff
(99.4 %id)
BP275406 Kidney .b 189 to 772 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DB486199 hypothalamus .b 190 to 613 1 to 425       423/425
(99 %)
3 diff
(99.3 %id)
DB455595 testis .b 191 to 651 1 to 461       461/461
(100 %)
0 diff
(100 %id)
CF131822 Chondrosarcoma Lung Metastasis cell lines, lung .b 191 to 884 1 to 694       694/694
(100 %)
2 diff
(99.8 %id)
TI_159677990   .b 191 to 1208 46 to 1053       1008/1062
(94 %)
19 diff
(98.3 %id)
AK312586 brain .b 192 to 1917 1 to 1726 exact     1726/1726
(100 %)
0 diff
(100 %id)
DA527170 brain .b 193 to 780 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB478886 hippocampus .b 193 to 690 1 to 498       498/498
(100 %)
0 diff
(100 %id)
CB268239 adipose .b 194 to 915 1 to 726       726/733
(99 %)
5 diff
(99.4 %id)
DA694052   .b 194 to 776 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA730028   .b 194 to 999 2 to 806   capped   805/805
(100 %)
2 diff
(99.8 %id)
DA930593 small intestine .b 194 to 788 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
TI_44185400   .b 195 to 989 35 to 829       795/829
(95 %)
6 diff
(99.3 %id)
AF026291   .b 196 to 2179 1 to 1984 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1984/1984
(100 %)
0 diff
(100 %id)
DA042993 bladder .b 197 to 780 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BC106934 PCR rescued clones .b 198 to 2043 1 to 1846 exact     1846/1846
(100 %)
0 diff
(100 %id)
TI_44348435   .b 198 to 988 101 to 895       795/898
(88 %)
11 diff
(98.8 %id)
AU076429   .b 200 to 347 1 to 148       148/148
(100 %)
0 diff
(100 %id)
DB460193 testis .b 200 to 667 1 to 468       468/468
(100 %)
0 diff
(100 %id)
BM750952 Ascites, stomach .b 200 to 796 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BM720579 eye, fetal eye .b 200 to 921 1 to 722     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 722/722
(100 %)
1 diff
(99.9 %id)
BC106933 PCR rescued clones .b 201 to 2043 1 to 1843 exact     1843/1843
(100 %)
0 diff
(100 %id)
DA204943 brain .b 201 to 792 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BP223120 colon mucosa .b 201 to 872 1 to 678       678/682
(99 %)
14 diff
(98.0 %id)
DA251002 caudate nucleus .b 203 to 783 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA351390 substantia nigra .b 203 to 788 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DC414377 trachea .b 203 to 801 1 to 600       600/600
(100 %)
4 diff
(99.4 %id)
TI_45213021   .b 205 to 1016 86 to 903       816/903
(90 %)
21 diff
(97.7 %id)
TI_154169750   .b 205 to 822 77 to 693       617/837
(73 %)
10 diff
(98.9 %id)
TI_154171854   .b 205 to 766 81 to 642       562/562
(100 %)
3 diff
(99.5 %id)
TI_151770406   .b 205 to 901 109 to 805       697/983
(70 %)
7 diff
(99.3 %id)
BM701714 eye, optic nerve .b 206 to 924 1 to 719     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 719/723
(99 %)
3 diff
(99.6 %id)
DB472362 hippocampus .b 208 to 700 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
DB482815 hippocampus .b 208 to 702 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
DB483725 hippocampus .b 208 to 658 1 to 451       451/451
(100 %)
0 diff
(100 %id)
DB493789 hypothalamus .b 208 to 718 1 to 509       509/518
(98 %)
2 diff
(99.7 %id)
CB130049 Liver .b 208 to 843 1 to 636       636/636
(100 %)
0 diff
(100 %id)
CB134919 Liver .b 208 to 844 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CB135732 Liver .b 208 to 886 1 to 679       679/679
(100 %)
0 diff
(100 %id)
CB139081 Liver .b 208 to 871 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
CB148861 Liver .b 208 to 885 1 to 678       678/678
(100 %)
0 diff
(100 %id)
BP314725 mammary gland .b 208 to 788 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM554061 amelanotic melanoma, cell line, skin .b 210 to 1215 1 to 1010       1008/1123
(89 %)
26 diff
(97.7 %id)
DA645668 mammary gland .b 212 to 1068 2 to 858   capped   857/857
(100 %)
9 diff
(99.0 %id)
BP341823 stomach mucosa .b 213 to 796 1 to 584       584/584
(100 %)
0 diff
(100 %id)
TI_44167947   .b 222 to 1050 126 to 953       828/969
(85 %)
34 diff
(96.5 %id)
TI_44168114   .b 222 to 987 149 to 919       769/920
(83 %)
14 diff
(98.5 %id)
DB031137 testis .b 223 to 823 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
BP192712 brain .b 225 to 806 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP197217 adrenal gland .b 225 to 807 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AK129860 heart .b 225 to 2179 1 to 1955 exact available from FLJ,   1955/1955
(100 %)
0 diff
(100 %id)
AU136161 placenta .b 226 to 941 2 to 719   capped   718/753
(95 %)
3 diff
(99.7 %id)
CN370558 embryonic stem cells, cell lines H1, H7, andH9 .b 239 to 960 1 to 722       722/722
(100 %)
0 diff
(100 %id)
ES310305 scalp interfollicular dermis, skin .b 241 to 817 1 to 578       579/578
(100 %)
9 diff
(98.5 %id)
BE269977 Burkitt lymphoma, lymph .b 241 to 917 1 to 676       676/677
(99 %)
3 diff
(99.6 %id)
BY997449   .b 241 to 888 4 to 663       672/663
(101 %)
56 diff
(91.6 %id)
CN370552 embryonic stem cells, cell lines H1, H7, andH9 .b 247 to 918 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BE902609 choriocarcinoma, placenta .b 260 to 1082 1 to 822       822/1201
(68 %)
28 diff
(97.7 %id)
TI_59390018   .b 271 to 987 62 to 777       716/718
(99 %)
9 diff
(98.8 %id)
U38846   .b 298 to 2180 1 to 1883 R435A     1883/1883
(100 %)
2 diff
(99.9 %id)
BX370391   .b 347 to 822 476 to 1     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
W95445 heart .b 347 to 841 1 to 502     Submitted on the opposite strand 502/507
(99 %)
10 diff
(98.1 %id)
AA258278 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 347 to 815 1 to 466     Submitted on the opposite strand 468/466
(100 %)
8 diff
(98.3 %id)
AI188701 placenta .b 347 to 966 1 to 620     Submitted on the opposite strand 620/620
(100 %)
0 diff
(100 %id)
AA447789 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 348 to 601 1 to 253     Submitted on the opposite strand 255/253
(100 %)
4 diff
(98.5 %id)
BG695999 skin .b 349 to 416 72 to 5     Submitted on the opposite strand 68/72
(94 %)
5 diff
(93.1 %id)
R24214 placenta .b 354 to 647 1 to 294     Submitted on the opposite strand 294/496
(59 %)
5 diff
(99.0 %id)
BM805953 brain, hippocampus .b 355 to 796 461 to 20     Submitted on the opposite strand 442/461
(95 %)
0 diff
(100 %id)
BQ215539 embryonal carcinoma, cell line, testis .b 355 to 1147 799 to 7     Submitted on the opposite strand 793/799
(99 %)
1 diff
(99.9 %id)
CX867031 embryonic stem .b 355 to 1107 1 to 753     Submitted on the opposite strand 753/753
(100 %)
0 diff
(100 %id)
BQ188459 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 355 to 903 551 to 3     Submitted on the opposite strand 549/551
(99 %)
0 diff
(100 %id)
N74873 lung .b 369 to 650 1 to 283     Submitted on the opposite strand 283/294
(96 %)
7 diff
(97.7 %id)
AI337897 uterus .b 369 to 978 1 to 610     Submitted on the opposite strand 610/610
(100 %)
0 diff
(100 %id)
AI022550 parathyroid gland, parathyroid tumor .b 372 to 424 1 to 52     Submitted on the opposite strand 52/52
(100 %)
1 diff
(98.1 %id)
EL946529 eyeball .b 375 to 958 8 to 591       584/591
(98 %)
9 diff
(98.5 %id)
H82267 melanocyte .b 385 to 803 26 to 459     Submitted on the opposite strand 434/463
(93 %)
23 diff
(95.1 %id)
BG314653   .b 396 to 475 85 to 6       80/85
(94 %)
0 diff
(100 %id)
H25166 breast .b 419 to 735 19 to 342     Submitted on the opposite strand 328/347
(94 %)
12 diff
(96.6 %id)
AA834417 adenocarcinoma, colon .b 429 to 740 1 to 311       311/313
(99 %)
23 diff
(92.7 %id)
AA737624 germinal center B cell .b 438 to 726 1 to 289     Submitted on the opposite strand 289/289
(100 %)
18 diff
(93.8 %id)
CN370526 embryonic stem cells, DMSO-treated H9 cellline .b 442 to 1062 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BY995674   .b 459 to 1129 40 to 710       671/710
(94 %)
9 diff
(98.8 %id)
BM469624 embryonal carcinoma, cell line, testis .b 469 to 1429 1 to 964       964/1013
(95 %)
24 diff
(97.7 %id)
BI093525 cervix .b 473 to 1263 1 to 794       794/794
(100 %)
4 diff
(99.5 %id)
ES308558 beard hair, skin .b 474 to 697 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
DN602223 human embryonic stem cells .b 484 to 1280 1 to 797       797/797
(100 %)
0 diff
(100 %id)
TI_154179179   .b 487 to 1214 74 to 794       721/903
(79 %)
14 diff
(98.5 %id)
BM709943 eye, Retina Foveal and Macular .b 488 to 919 1 to 432     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 432/432
(100 %)
3 diff
(99.4 %id)
CX165177 human embryonic stem cells differentiated toan early endodermal cell type .b 489 to 1272 1 to 784       784/784
(100 %)
1 diff
(99.9 %id)
CX786488 human embryonic stem cells .b 489 to 1258 1 to 770       770/770
(100 %)
0 diff
(100 %id)
AA258277 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 520 to 1031 514 to 3     Submitted on the opposite strand 512/514
(99 %)
2 diff
(99.7 %id)
AA453721 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 520 to 1065 559 to 14     Submitted on the opposite strand 546/559
(97 %)
0 diff
(100 %id)
TI_59394386   .b 520 to 1290 93 to 865       773/777
(99 %)
9 diff
(98.9 %id)
BQ291746 amnion_normal .b 533 to 781 248 to 1       248/250
(99 %)
3 diff
(98.8 %id)
F07190 brain, total brain .b 539 to 883 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
CN370555 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 556 to 1255 1 to 700       700/700
(100 %)
0 diff
(100 %id)
TI_57148438   .b 561 to 1267 48 to 784       732/784
(93 %)
46 diff
(94.2 %id)
CN370549 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 565 to 1197 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
TI_154180094   .b 567 to 1219 73 to 725       653/850
(76 %)
22 diff
(97.5 %id)
TI_154181804   .b 567 to 1311 70 to 809       740/882
(83 %)
11 diff
(98.8 %id)
TI_154182014   .b 567 to 1413 76 to 910       835/836
(99 %)
17 diff
(98.0 %id)
BG390694 embryonal carcinoma, cell line, testis .b 588 to 1309 1 to 720       720/1001
(71 %)
8 diff
(99.3 %id)
CR615372 Placenta Cot 25-normalized .b 595 to 2076 1 to 1482       1482/1482
(100 %)
0 diff
(100 %id)
AL546912 placenta, Placenta Cot 25-normalized .b 595 to 1342 1 to 748   fully sequenced,   748/748
(100 %)
0 diff
(100 %id)
BX341463   .b 597 to 1654 1050 to 1     Submitted on the opposite strand 1050/1050
(100 %)
8 diff
(99.3 %id)
BU178374 melanotic melanoma, skin .b 614 to 1450 1 to 836       836/846
(98 %)
2 diff
(99.8 %id)
BQ310664 breast_normal .b 624 to 941 321 to 5       317/321
(98 %)
3 diff
(99.1 %id)
BF816277 colon_ins .b 630 to 778 165 to 16     Submitted on the opposite strand 150/165
(90 %)
0 diff
(100 %id)
AW998988 breast_normal .b 650 to 912 265 to 4     Submitted on the opposite strand 262/269
(97 %)
5 diff
(98.2 %id)
TI_154137660   .b 654 to 1514 78 to 925       852/862
(98 %)
38 diff
(95.6 %id)
AU123809   .b 661 to 1316 2 to 659   capped   658/682
(96 %)
8 diff
(98.9 %id)
F07476 brain, total brain .b 662 to 1010 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
TI_57230242   .b 677 to 1413 86 to 827       742/747
(99 %)
14 diff
(98.2 %id)
BF818832 colon_ins .b 689 to 919 231 to 1     Submitted on the opposite strand 231/239
(96 %)
2 diff
(99.2 %id)
TI_59385162   .b 690 to 1429 99 to 839       741/828
(89 %)
19 diff
(97.8 %id)
CR619877 Neuroblastoma Cot 25-normalized .b 691 to 2078 1 to 1388       1388/1388
(100 %)
0 diff
(100 %id)
CB159262 Liver .b 691 to 1378 1 to 688       688/688
(100 %)
0 diff
(100 %id)
TI_154187557   .b 694 to 1219 118 to 643       526/965
(54 %)
15 diff
(98.5 %id)
R24213 placenta .b 700 to 1121 439 to 1     Submitted on the opposite strand 416/439
(94 %)
30 diff
(93.2 %id)
TI_154138510   .b 700 to 1210 80 to 590       511/512
(99 %)
12 diff
(97.7 %id)
CR620064 Neuroblastoma Cot 10-normalized .b 702 to 2092 1 to 1391       1391/1391
(100 %)
0 diff
(100 %id)
AL520294 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 702 to 1245 1 to 544   fully sequenced,   544/544
(100 %)
0 diff
(100 %id)
CR622073 Neuroblastoma Cot 25-normalized .b 707 to 2077 1 to 1371       1371/1371
(100 %)
0 diff
(100 %id)
H27427 breast .b 732 to 1165 448 to 4     Submitted on the opposite strand 445/456
(97 %)
11 diff
(97.6 %id)
H82373 melanocyte .b 734 to 1175 454 to 2     Submitted on the opposite strand 451/458
(98 %)
13 diff
(97.2 %id)
R77558 placenta .b 751 to 1121 380 to 2     Submitted on the opposite strand 379/445
(85 %)
13 diff
(97.1 %id)
FN096597 breast carcinoma .b 757 to 819 1 to 64       64/65
(98 %)
2 diff
(97.0 %id)
CX787799 human embryonic stem cells .b 764 to 1545 1 to 782       782/782
(100 %)
0 diff
(100 %id)
BU155460 melanotic melanoma, skin .b 775 to 1553 1 to 786       786/861
(91 %)
14 diff
(98.4 %id)
CR992514 T-Lymphocytes .b 778 to 1631 1 to 854       854/857
(99 %)
1 diff
(99.9 %id)
TI_154140292   .b 778 to 1365 85 to 672       588/588
(100 %)
2 diff
(99.7 %id)
TI_57218541   .b 794 to 1429 72 to 715       644/865
(74 %)
20 diff
(97.7 %id)
BP277268 Kidney .b 813 to 1395 1 to 583       583/583
(100 %)
0 diff
(100 %id)
TI_57231271   .b 816 to 1648 57 to 891       835/859
(97 %)
14 diff
(98.4 %id)
BM454563 embryonal carcinoma, cell line, testis .b 823 to 1475 1 to 654       654/1041
(62 %)
8 diff
(99.3 %id)
R82569 placenta .b 850 to 1134 289 to 1     Submitted on the opposite strand 289/421
(68 %)
4 diff
(99.1 %id)
AA088371 colon, tumor .b 859 to 1260 1 to 402       402/402
(100 %)
0 diff
(100 %id)
TI_154180131   .b 865 to 1715 75 to 919       845/847
(99 %)
15 diff
(98.3 %id)
CX787235 human embryonic stem cells .b 866 to 1537 1 to 672       672/672
(100 %)
0 diff
(100 %id)
H27409 breast .b 868 to 973 106 to 1     Submitted on the opposite strand 106/106
(100 %)
1 diff
(99.1 %id)
BU508059 leiomyosarcoma, uterus .b 868 to 1787 1 to 922       922/1181
(78 %)
6 diff
(99.5 %id)
TI_154172079   .b 870 to 1469 77 to 676       600/601
(99 %)
3 diff
(99.6 %id)
TI_151807827   .b 870 to 1650 107 to 886       780/786
(99 %)
35 diff
(95.6 %id)
TI_57145837   .b 877 to 1786 69 to 975       907/975
(93 %)
16 diff
(98.4 %id)
W05707 lung .b 885 to 1136 252 to 1     Submitted on the opposite strand 252/253
(99 %)
0 diff
(100 %id)
BE174900 head_neck .b 890 to 1122 265 to 32     Submitted on the opposite strand 234/280
(83 %)
0 diff
(100 %id)
BU148752 eye, retinoblastoma .b 923 to 1787 1 to 872       872/896
(97 %)
13 diff
(98.6 %id)
BM765256 stomach .b 926 to 1631 1 to 706       706/706
(100 %)
0 diff
(100 %id)
TI_154172899   .b 936 to 1554 94 to 714       621/1229
(50 %)
8 diff
(99.4 %id)
TI_154173052   .b 936 to 1497 85 to 652       568/1319
(43 %)
14 diff
(99.0 %id)
BQ049248 lymph, lymphoma, cell line .b 943 to 1759 834 to 16   AAA Submitted on the opposite strand 819/986
(83 %)
9 diff
(99.1 %id)
TI_57231036   .b 947 to 1409 52 to 515       464/465
(99 %)
2 diff
(99.6 %id)
BG260990 bladder, transitional cell papilloma, cell line .b 952 to 1699 1 to 747       747/970
(77 %)
21 diff
(97.9 %id)
BG105442 adrenal cortex carcinoma, cell line, adrenal gland .b 954 to 1707 1 to 760       760/960
(79 %)
16 diff
(98.4 %id)
BI766672 pooled lung and spleen .b 968 to 1783 810 to 1     Submitted on the opposite strand 810/812
(99 %)
7 diff
(99.2 %id)
TI_57181254   .b 968 to 1783 872 to 63     Submitted on the opposite strand 810/874
(92 %)
7 diff
(99.2 %id)
TI_159676321   .b 1013 to 1789 52 to 825       774/1036
(74 %)
12 diff
(98.9 %id)
BM461874 leiomyosarcoma, uterus .b 1063 to 1903 1 to 858       856/898
(95 %)
29 diff
(96.8 %id)
BM693742 eye, lens .b 1064 to 1631 1 to 568   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 568/568
(100 %)
3 diff
(99.5 %id)
BE383170 brain, neuroblastoma .b 1077 to 1735 1 to 659       659/660
(99 %)
3 diff
(99.6 %id)
BM925165 pooled lung and spleen .b 1077 to 1982 916 to 12     Submitted on the opposite strand 905/1060
(85 %)
7 diff
(99.4 %id)
BQ350268 head_neck .b 1082 to 1641 575 to 16       560/575
(97 %)
3 diff
(99.5 %id)
CD102142 Pooled-Skin .b 1101 to 1787 1 to 694       694/740
(93 %)
12 diff
(98.4 %id)
BQ344400 nervous_tumor .b 1129 to 1508 406 to 27       380/406
(93 %)
2 diff
(99.6 %id)
CB160085 Liver .b 1146 to 1754 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CR608512 HeLa cells Cot 25-normalized .b 1151 to 2151 1 to 1001       1001/1001
(100 %)
0 diff
(100 %id)
AL556589 placenta .b 1151 to 1819 1 to 669   fully sequenced,   669/669
(100 %)
0 diff
(100 %id)
BC014676 Brain, anaplastic oligodendroglioma with1p/19q loss .b 1164 to 2148 1 to 985   available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 985/985
(100 %)
0 diff
(100 %id)
BM311022 Pancreas, Purified pancreatic islet .b 1165 to 1789 1 to 626       626/627
(99 %)
6 diff
(99.1 %id)
EL954246 eyeball .b 1167 to 1586 1 to 425       425/425
(100 %)
9 diff
(97.9 %id)
AL520293 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1184 to 2092 909 to 1   fully sequenced,   909/909
(100 %)
2 diff
(99.8 %id)
BU539303 adenocarcinoma, cell line, breast .b 1192 to 1788 1 to 606       606/1006
(60 %)
16 diff
(98.5 %id)
BM469065 embryonal carcinoma, cell line, testis .b 1200 to 2105 930 to 17   AAA Submitted on the opposite strand 914/970
(94 %)
15 diff
(98.5 %id)
TI_57193739   .b 1212 to 1948 45 to 781       737/737
(100 %)
6 diff
(99.2 %id)
BP206959 coronary artery .b 1213 to 1789 1 to 577       577/584
(98 %)
2 diff
(99.7 %id)
BG199488   .b 1215 to 1787 1 to 572       572/798
(71 %)
9 diff
(98.9 %id)
BG203111   .b 1215 to 1789 42 to 616       576/833
(69 %)
16 diff
(98.1 %id)
AA512848 Ewing's sarcoma .b 1215 to 1302 1 to 88       88/88
(100 %)
7 diff
(92.1 %id)
CN370523 embryonic stem cells, DMSO-treated H9 cellline .b 1216 to 1789 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
TI_149296128   .b 1237 to 2179 999 to 80   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 921/964
(95 %)
32 diff
(96.7 %id)
BQ304038 breast .b 1241 to 1548 314 to 7       308/314
(98 %)
1 diff
(99.7 %id)
BQ651452 hepatocellular carcinoma, cell line, Liver .b 1251 to 2105 1 to 856   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 856/856
(100 %)
3 diff
(99.7 %id)
BQ651510 hepatocellular carcinoma, cell line, Liver .b 1251 to 2098 1 to 844   AAA   844/851
(99 %)
16 diff
(98.2 %id)
BQ645185 hepatocellular carcinoma, cell line, Liver .b 1251 to 2104 1 to 868       868/934
(92 %)
21 diff
(97.8 %id)
BQ651847 hepatocellular carcinoma, cell line, Liver .b 1251 to 2104 1 to 857   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 857/857
(100 %)
8 diff
(99.1 %id)
BU185554 ductal carcinoma, cell line, Pancreas .b 1263 to 2106 856 to 9     Submitted on the opposite strand 848/868
(97 %)
5 diff
(99.5 %id)
BM699688 eye, lens .b 1274 to 1703 1 to 430   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
BQ269997 Pancreas, Purified pancreatic islet .b 1277 to 1819 1 to 543   fully sequenced,   543/543
(100 %)
0 diff
(100 %id)
BM700497 eye, lens .b 1279 to 1958 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
AL572161 placenta, Placenta Cot 25-normalized .b 1281 to 2076 795 to 1   fully sequenced,   796/796
(100 %)
6 diff
(99.3 %id)
BM696274 eye, lens .b 1281 to 1817 1 to 537   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
CV356393 nervous_tumor .b 1285 to 1766 582 to 98     Submitted on the opposite strand 485/582
(83 %)
2 diff
(99.7 %id)
CV356360 nervous_tumor .b 1286 to 1790 602 to 97     Submitted on the opposite strand 506/602
(84 %)
7 diff
(98.9 %id)
BQ215666 embryonal carcinoma, cell line, testis .b 1297 to 1787 879 to 387   AAA Submitted on the opposite strand 493/572
(86 %)
15 diff
(97.4 %id)
TI_154060594   .b 1300 to 2168 949 to 91   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 859/976
(88 %)
38 diff
(96.2 %id)
TI_149285444   .b 1302 to 2179 952 to 91   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 863/1127
(76 %)
24 diff
(97.9 %id)
TI_154047832   .b 1302 to 2105 891 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 804/940
(85 %)
15 diff
(98.5 %id)
CB105425 Liver .b 1305 to 1948 1 to 644       644/644
(100 %)
0 diff
(100 %id)
TI_149282941   .b 1305 to 2111 871 to 79   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 793/798
(99 %)
19 diff
(97.7 %id)
CV340664 lung_tumor .b 1306 to 1793 10 to 508       494/515
(95 %)
39 diff
(92.5 %id)
TI_149314927   .b 1306 to 2173 943 to 92   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 852/980
(86 %)
20 diff
(98.0 %id)
TI_154060856   .b 1306 to 2179 947 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 861/974
(88 %)
19 diff
(98.1 %id)
BM790891 stomach .b 1307 to 1932 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BM791411 stomach .b 1307 to 1950 1 to 644       644/644
(100 %)
0 diff
(100 %id)
TI_149303158   .b 1310 to 2105 866 to 73   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 794/965
(82 %)
4 diff
(99.6 %id)
BQ216700 embryonal carcinoma, cell line, testis .b 1311 to 2179 885 to 18   AAA Submitted on the opposite strand 868/868
(100 %)
1 diff
(99.9 %id)
CF242962 Brain glioblastoma .b 1313 to 2105 822 to 29   AAA Submitted on the opposite strand 794/840
(94 %)
7 diff
(99.2 %id)
TI_149300717   .b 1314 to 2179 923 to 58   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 866/1022
(84 %)
20 diff
(98.1 %id)
BG217838   .b 1317 to 2171 866 to 16     Submitted on the opposite strand 852/888
(95 %)
50 diff
(94.4 %id)
BM981216 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1319 to 2105 803 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 785/785
(100 %)
3 diff
(99.7 %id)
CV356338 nervous_tumor .b 1321 to 1745 433 to 4     Submitted on the opposite strand 430/447
(96 %)
19 diff
(95.8 %id)
BG198959   .b 1324 to 2171 859 to 16     Submitted on the opposite strand 844/860
(98 %)
27 diff
(96.9 %id)
FN104962 breast carcinoma .b 1325 to 1368 49 to 6     Submitted on the opposite strand 44/50
(88 %)
0 diff
(100 %id)
FN063772 breast carcinoma .b 1332 to 1417 1 to 83       83/83
(100 %)
3 diff
(96.4 %id)
BG205688   .b 1335 to 2171 851 to 14     Submitted on the opposite strand 838/852
(98 %)
22 diff
(97.5 %id)
BG221299   .b 1337 to 2172 849 to 14     Submitted on the opposite strand 836/851
(98 %)
32 diff
(96.3 %id)
CV341246 placenta_normal .b 1339 to 1902 586 to 23     Submitted on the opposite strand 564/586
(96 %)
3 diff
(99.5 %id)
TI_154062657   .b 1341 to 2105 851 to 89   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 665/963
(69 %)
85 diff
(91.2 %id)
BQ212866 large cell carcinoma, lung .b 1356 to 2179 874 to 50   AAA Submitted on the opposite strand 825/825
(100 %)
6 diff
(99.3 %id)
BQ216746 epithelioid carcinoma, Pancreas .b 1361 to 1757 402 to 1     Submitted on the opposite strand 402/817
(49 %)
11 diff
(98.7 %id)
FN143646 breast carcinoma .b 1365 to 1464 101 to 1     Submitted on the opposite strand 101/105
(96 %)
1 diff
(99.1 %id)
BE867406 adenocarcinoma, colon .b 1365 to 2144 779 to 1     Submitted on the opposite strand 779/866
(89 %)
13 diff
(98.5 %id)
CV356441 nervous_tumor .b 1366 to 1927 566 to 6     Submitted on the opposite strand 561/566
(99 %)
10 diff
(98.3 %id)
BI090847 cervix .b 1366 to 2103 739 to 1     Submitted on the opposite strand 739/739
(100 %)
3 diff
(99.6 %id)
TI_154131156   .b 1369 to 2173 885 to 90   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 796/957
(83 %)
12 diff
(98.8 %id)
BQ315768 colon .b 1370 to 1662 294 to 1       294/296
(99 %)
3 diff
(99.0 %id)
BQ315817 colon .b 1370 to 1662 294 to 1       294/296
(99 %)
3 diff
(99.0 %id)
TI_59384580   .b 1372 to 2036 58 to 723       666/666
(100 %)
3 diff
(99.6 %id)
BG183938   .b 1373 to 2171 814 to 17     Submitted on the opposite strand 798/814
(98 %)
6 diff
(99.3 %id)
BG200512   .b 1373 to 2171 815 to 17     Submitted on the opposite strand 799/815
(98 %)
5 diff
(99.4 %id)
BG220362   .b 1375 to 2171 805 to 15     Submitted on the opposite strand 792/885
(89 %)
18 diff
(98.0 %id)
CX786772 human embryonic stem cells .b 1375 to 2179 831 to 27   AAA Submitted on the opposite strand 805/805
(100 %)
1 diff
(99.9 %id)
BG217833   .b 1376 to 2171 811 to 18     Submitted on the opposite strand 794/817
(97 %)
15 diff
(98.2 %id)
BG219330   .b 1376 to 2171 811 to 16     Submitted on the opposite strand 796/830
(95 %)
27 diff
(96.8 %id)
BQ330923 lung_tumor .b 1378 to 1902 540 to 17       524/544
(96 %)
4 diff
(99.3 %id)
BG181877   .b 1387 to 2171 794 to 16     Submitted on the opposite strand 780/820
(95 %)
12 diff
(98.6 %id)
TI_154020224   .b 1403 to 2105 792 to 90   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 703/705
(99 %)
6 diff
(99.2 %id)
FN057638 breast carcinoma .b 1406 to 1509 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
CX758956 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1408 to 2105 719 to 22   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 698/700
(99 %)
0 diff
(100 %id)
BG182898   .b 1414 to 2171 776 to 17     Submitted on the opposite strand 760/880
(86 %)
23 diff
(97.4 %id)
BG200018   .b 1414 to 2180 775 to 10     Submitted on the opposite strand 766/850
(90 %)
47 diff
(94.5 %id)
CX166254 human embryonic stem cells differentiated toan early endodermal cell type .b 1414 to 2173 785 to 26   AAA Submitted on the opposite strand 760/760
(100 %)
0 diff
(100 %id)
BQ014824 Chondrosarcoma, Left Pubic Bone .b 1415 to 2105 709 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 691/691
(100 %)
0 diff
(100 %id)
BG182391   .b 1417 to 2171 770 to 15     Submitted on the opposite strand 756/885
(85 %)
24 diff
(97.3 %id)
BG191805   .b 1417 to 2171 765 to 15     Submitted on the opposite strand 751/879
(85 %)
34 diff
(96.2 %id)
BG193380   .b 1417 to 2171 766 to 15     Submitted on the opposite strand 752/837
(89 %)
15 diff
(98.3 %id)
BG205682   .b 1417 to 2171 766 to 15     Submitted on the opposite strand 752/825
(91 %)
27 diff
(96.8 %id)
BG209881   .b 1417 to 2171 766 to 18     Submitted on the opposite strand 749/886
(84 %)
11 diff
(98.8 %id)
BG213032   .b 1417 to 2171 761 to 14     Submitted on the opposite strand 748/837
(89 %)
30 diff
(96.5 %id)
BG215168   .b 1417 to 2171 769 to 15     Submitted on the opposite strand 755/820
(92 %)
11 diff
(98.7 %id)
BG219337   .b 1417 to 2171 766 to 17     Submitted on the opposite strand 750/891
(84 %)
22 diff
(97.6 %id)
H85273 melanocyte .b 1417 to 1766 360 to 9     Submitted on the opposite strand 352/428
(82 %)
6 diff
(98.6 %id)
BG388070 embryonal carcinoma, cell line, testis .b 1417 to 2183 762 to 1     Submitted on the opposite strand 762/786
(96 %)
8 diff
(99.0 %id)
TI_149297108   .b 1417 to 2179 844 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 758/927
(81 %)
9 diff
(99.1 %id)
TI_149298235   .b 1417 to 2179 844 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 757/941
(80 %)
9 diff
(99.1 %id)
TI_149310125   .b 1417 to 2179 839 to 80   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 760/947
(80 %)
7 diff
(99.3 %id)
TI_154124866   .b 1417 to 2105 774 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 683/930
(73 %)
6 diff
(99.4 %id)
TI_154130941   .b 1419 to 2173 837 to 85   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 753/995
(75 %)
6 diff
(99.4 %id)
BG181876   .b 1420 to 2171 758 to 14     Submitted on the opposite strand 740/877
(84 %)
13 diff
(98.6 %id)
BG197921   .b 1420 to 2171 768 to 17     Submitted on the opposite strand 752/834
(90 %)
22 diff
(97.4 %id)
BG205683   .b 1420 to 2171 769 to 16     Submitted on the opposite strand 747/816
(91 %)
18 diff
(97.8 %id)
BG219331   .b 1420 to 2170 763 to 15     Submitted on the opposite strand 749/822
(91 %)
6 diff
(99.3 %id)
BQ423207 melanotic melanoma, skin .b 1420 to 2105 757 to 66   AAA Submitted on the opposite strand 692/746
(92 %)
12 diff
(98.4 %id)
TI_149286823   .b 1420 to 2187 833 to 64   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 770/1333
(57 %)
14 diff
(99.0 %id)
BG195390   .b 1421 to 2171 769 to 17     Submitted on the opposite strand 753/826
(91 %)
19 diff
(97.7 %id)
TI_149275381   .b 1421 to 2105 763 to 83   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 681/718
(94 %)
16 diff
(97.8 %id)
BG209412   .b 1423 to 2171 766 to 19     Submitted on the opposite strand 743/844
(88 %)
28 diff
(96.7 %id)
BG181875   .b 1425 to 2171 756 to 17     Submitted on the opposite strand 740/836
(88 %)
10 diff
(98.9 %id)
BQ774942 Bone, Human Chondrosarcoma Cell Line .b 1428 to 2105 696 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
BQ775947 Bone, Human Chondrosarcoma Cell Line .b 1428 to 2105 696 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 678/678
(100 %)
1 diff
(99.9 %id)
BE931793 head_neck .b 1431 to 1549 129 to 10       120/129
(93 %)
0 diff
(100 %id)
BG220354   .b 1433 to 2171 756 to 17     Submitted on the opposite strand 740/818
(90 %)
9 diff
(98.9 %id)
BG194387   .b 1434 to 2171 753 to 18     Submitted on the opposite strand 736/839
(87 %)
23 diff
(97.3 %id)
TI_149310357   .b 1436 to 2105 742 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 659/841
(78 %)
21 diff
(97.6 %id)
FN171254 breast carcinoma .b 1443 to 1522 1 to 81       81/81
(100 %)
3 diff
(96.3 %id)
CD366062 Alveolar Macrophage, lung .b 1444 to 2179 749 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
BQ575848 Chondrosarcoma Grade II, Left Pelvis .b 1445 to 2098 672 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
BQ776179 Bone, Human Chondrosarcoma Cell Line .b 1445 to 2173 738 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 725/725
(100 %)
5 diff
(99.4 %id)
BU631550 cell lines, Chondrosarcoma .b 1445 to 2179 750 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 732/732
(100 %)
5 diff
(99.4 %id)
TI_44185402   .b 1446 to 2033 606 to 5       602/693
(86 %)
19 diff
(97.3 %id)
AI743097 pooled .b 1451 to 2179 742 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 728/765
(95 %)
8 diff
(99.0 %id)
AA191142   .b 1454 to 1819 1 to 369   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 369/369
(100 %)
3 diff
(99.2 %id)
BG166244 hypernephroma, cell line, Kidney .b 1461 to 2105 700 to 57     Submitted on the opposite strand 644/725
(88 %)
24 diff
(96.7 %id)
BQ775456 Bone, Human Chondrosarcoma Cell Line .b 1461 to 2179 736 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 718/718
(100 %)
1 diff
(99.9 %id)
CA422412 cell lines, Chondrosarcoma .b 1461 to 2179 735 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 717/717
(100 %)
1 diff
(99.9 %id)
BU684654 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1464 to 2179 731 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 713/717
(99 %)
4 diff
(99.5 %id)
CA430491 Cell Line, Chondrosarcoma .b 1464 to 2176 725 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 710/711
(99 %)
2 diff
(99.8 %id)
BF740271 brain, oligodendroglioma .b 1465 to 2174 710 to 1       710/710
(100 %)
2 diff
(99.8 %id)
CR600967 Placenta Cot 25-normalized .b 1467 to 2184 1 to 718       718/718
(100 %)
0 diff
(100 %id)
AA126359 uterus .b 1469 to 1819 1 to 351   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
BQ292346 amnion_normal .b 1470 to 1733 269 to 5       265/277
(95 %)
3 diff
(99.0 %id)
BE786590 large cell carcinoma, lung .b 1471 to 2105 670 to 25   AAA Submitted on the opposite strand 646/895
(72 %)
54 diff
(94.0 %id)
BQ020948 lung, Metastatic Chondrosarcoma .b 1476 to 2105 648 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 630/630
(100 %)
0 diff
(100 %id)
CA307838 Alveolar Macrophage, lung .b 1476 to 2179 722 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 704/704
(100 %)
0 diff
(100 %id)
FN073784 breast carcinoma .b 1478 to 1549 71 to 1     Submitted on the opposite strand 71/73
(97 %)
1 diff
(98.7 %id)
CA417962 Bone, Human Chondrosarcoma Cell Line .b 1478 to 2173 708 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
CA418052 Bone, Human Chondrosarcoma Cell Line .b 1478 to 2173 707 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 694/694
(100 %)
2 diff
(99.8 %id)
BM982233 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1479 to 2179 718 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 700/700
(100 %)
1 diff
(99.9 %id)
CN370528 embryonic stem cells, cell lines H1, H7, andH9 .b 1481 to 2105 668 to 44   AAA Submitted on the opposite strand 625/625
(100 %)
0 diff
(100 %id)
CX763215 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1481 to 2184 707 to 4     Submitted on the opposite strand 704/707
(99 %)
0 diff
(100 %id)
BU630907 cell lines, Chondrosarcoma .b 1482 to 2107 644 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 626/626
(100 %)
0 diff
(100 %id)
BM311612 Pancreas, Purified pancreatic islet .b 1486 to 2104 619 to 1       619/619
(100 %)
2 diff
(99.7 %id)
BM677455 eye, fetal eye .b 1486 to 2173 696 to 12       685/696
(98 %)
1 diff
(99.9 %id)
CB306399 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1487 to 2173 698 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 685/685
(100 %)
1 diff
(99.9 %id)
BU740301 eye, lens .b 1487 to 2179 710 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 692/692
(100 %)
1 diff
(99.9 %id)
CA420237 Bone, Human Chondrosarcoma Cell Line .b 1487 to 2179 709 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 691/691
(100 %)
1 diff
(99.9 %id)
CA423253 cell lines, Chondrosarcoma .b 1488 to 2173 702 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
CX870599 embryonic stem .b 1489 to 2171 712 to 30     Submitted on the opposite strand 683/712
(95 %)
4 diff
(99.5 %id)
BI091886 cervix .b 1490 to 2179 1 to 690   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 690/690
(100 %)
0 diff
(100 %id)
TI_57188432   .b 1492 to 2180 54 to 741       688/908
(75 %)
9 diff
(99.1 %id)
BM666572 eye, optic nerve .b 1492 to 2105 630 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
BQ319018 colon .b 1493 to 1790 322 to 27       296/322
(91 %)
0 diff
(100 %id)
BU684154 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1494 to 2179 702 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
AW157037 brain, frontal lobe .b 1495 to 2184 692 to 3       690/692
(99 %)
1 diff
(99.9 %id)
CX761443 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1497 to 2184 690 to 4     Submitted on the opposite strand 687/690
(99 %)
7 diff
(99.0 %id)
BQ009422 Chondrosarcoma, Left Pubic Bone .b 1500 to 2179 696 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 678/678
(100 %)
1 diff
(99.9 %id)
BG220825   .b 1504 to 2168 684 to 19     Submitted on the opposite strand 666/846
(78 %)
6 diff
(99.3 %id)
FN105819 breast carcinoma .b 1507 to 1599 90 to 1     Submitted on the opposite strand 85/94
(90 %)
6 diff
(93.7 %id)
BQ329164 lung_normal .b 1508 to 1925 420 to 5       419/437
(95 %)
3 diff
(99.4 %id)
BM984867 lung .b 1512 to 2179 683 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 665/665
(100 %)
2 diff
(99.7 %id)
BG874951 breast .b 1516 to 1789 331 to 58       274/332
(82 %)
0 diff
(100 %id)
BG874952 breast .b 1516 to 1932 417 to 5       413/418
(98 %)
4 diff
(99.1 %id)
TI_154135938   .b 1532 to 2179 743 to 97   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 647/647
(100 %)
10 diff
(98.5 %id)
TI_149308598   .b 1534 to 2179 731 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 645/956
(67 %)
1 diff
(99.9 %id)
BM979782 lung, Primary Lung Epithelial Cells .b 1534 to 2179 663 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 645/663
(97 %)
1 diff
(99.9 %id)
FN154460 breast carcinoma .b 1538 to 1643 107 to 1     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
BG185515   .b 1540 to 2172 647 to 14     Submitted on the opposite strand 634/861
(73 %)
10 diff
(98.9 %id)
BG198967   .b 1543 to 2171 645 to 16     Submitted on the opposite strand 630/855
(73 %)
34 diff
(96.1 %id)
BP318017 pericardium .b 1544 to 2126 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AA149448 uterus .b 1545 to 1652 1 to 109   fully sequenced,   109/109
(100 %)
5 diff
(95.5 %id)
BG214120   .b 1546 to 2171 645 to 14     Submitted on the opposite strand 632/876
(72 %)
25 diff
(97.2 %id)
BG216800   .b 1546 to 2171 638 to 15     Submitted on the opposite strand 624/878
(71 %)
11 diff
(98.8 %id)
BG217307   .b 1546 to 2171 635 to 16     Submitted on the opposite strand 620/865
(71 %)
28 diff
(96.8 %id)
BG218856   .b 1546 to 2172 645 to 18     Submitted on the opposite strand 628/916
(68 %)
30 diff
(96.8 %id)
CA390170 eye, RPE/choroid .b 1551 to 2161 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BG194381   .b 1552 to 2136 587 to 4     Submitted on the opposite strand 584/822
(71 %)
14 diff
(98.3 %id)
BG205145   .b 1552 to 2171 633 to 16     Submitted on the opposite strand 618/636
(97 %)
16 diff
(97.5 %id)
BG216810   .b 1552 to 2171 641 to 18     Submitted on the opposite strand 624/872
(71 %)
16 diff
(98.2 %id)
BG201383   .b 1553 to 2168 634 to 17     Submitted on the opposite strand 618/867
(71 %)
10 diff
(98.9 %id)
BG208729   .b 1553 to 2161 622 to 16     Submitted on the opposite strand 607/851
(71 %)
24 diff
(97.2 %id)
BQ430192 large cell carcinoma, lung .b 1553 to 2105 578 to 27   AAA Submitted on the opposite strand 552/844
(65 %)
15 diff
(98.3 %id)
TI_154058697   .b 1554 to 2105 661 to 111   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 551/928
(59 %)
2 diff
(99.8 %id)
AA625230 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1561 to 2169 608 to 1     Submitted on the opposite strand 608/608
(100 %)
3 diff
(99.6 %id)
FN097449 breast carcinoma .b 1565 to 1641 1 to 76       76/76
(100 %)
3 diff
(96.1 %id)
CV389721 colon_ins .b 1566 to 1789 1 to 225       225/225
(100 %)
6 diff
(97.4 %id)
BG109660 Bone, osteosarcoma, cell line .b 1567 to 2267 1 to 700       700/701
(99 %)
4 diff
(99.5 %id)
BG212092   .b 1575 to 2170 663 to 64     Submitted on the opposite strand 600/909
(66 %)
39 diff
(95.8 %id)
AA046919 eye, retina .b 1577 to 2099 521 to 1     Submitted on the opposite strand 521/522
(99 %)
5 diff
(99.1 %id)
BQ292187 amnion_normal .b 1579 to 1906 364 to 36       329/364
(90 %)
10 diff
(97.3 %id)
CX867102 embryonic stem .b 1579 to 2105 562 to 36   AAA Submitted on the opposite strand 527/527
(100 %)
4 diff
(99.3 %id)
AU148430   .b 1579 to 2168 589 to 1       589/591
(99 %)
5 diff
(99.2 %id)
W63803 parathyroid gland, parathyroid tumor .b 1586 to 2161 567 to 1     Submitted on the opposite strand 567/567
(100 %)
14 diff
(97.6 %id)
FN138319 breast carcinoma .b 1588 to 1682 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
BU681091 lung .b 1595 to 2187 611 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
AA188152   .b 1596 to 2169 572 to 1     Submitted on the opposite strand 572/624
(91 %)
4 diff
(99.4 %id)
CX873114 embryonic stem .b 1596 to 2105 542 to 33   AAA Submitted on the opposite strand 510/510
(100 %)
14 diff
(97.3 %id)
BU738076 eye, lens .b 1601 to 2179 597 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
BU738183 eye, lens .b 1601 to 2179 597 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
BG193381   .b 1603 to 2171 584 to 14     Submitted on the opposite strand 571/836
(68 %)
21 diff
(97.5 %id)
TI_154188697   .b 1604 to 2184 703 to 124     Submitted on the opposite strand 580/895
(64 %)
24 diff
(97.4 %id)
FN161664 breast carcinoma .b 1606 to 1667 1 to 62       62/71
(87 %)
3 diff
(95.8 %id)
FN175192 breast carcinoma .b 1612 to 1702 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
FN150245 breast carcinoma .b 1614 to 1705 92 to 1     Submitted on the opposite strand 92/92
(100 %)
6 diff
(93.5 %id)
BG201023   .b 1622 to 2171 565 to 16     Submitted on the opposite strand 550/815
(67 %)
13 diff
(98.5 %id)
AU148555   .b 1624 to 2176 552 to 1       552/554
(99 %)
4 diff
(99.3 %id)
BG213556   .b 1627 to 2171 562 to 16     Submitted on the opposite strand 547/830
(65 %)
2 diff
(99.8 %id)
CR600123 HeLa cells Cot 25-normalized .b 1632 to 2493 1 to 862       862/862
(100 %)
0 diff
(100 %id)
AL555754 placenta .b 1632 to 2493 1 to 862   fully sequenced,   862/862
(100 %)
0 diff
(100 %id)
BM264388 Pancreas, Purified pancreatic islet .b 1642 to 1906 271 to 7     Submitted on the opposite strand 265/271
(97 %)
8 diff
(97.1 %id)
BG220363   .b 1648 to 2171 540 to 16     Submitted on the opposite strand 525/842
(62 %)
19 diff
(97.8 %id)
BG215174   .b 1649 to 2170 595 to 70     Submitted on the opposite strand 526/889
(59 %)
22 diff
(97.6 %id)
W95791 heart .b 1651 to 2106 456 to 1     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
AA151584 uterus .b 1651 to 1744 94 to 1   fully sequenced,   94/94
(100 %)
5 diff
(94.7 %id)
BM679298 eye, fetal eye .b 1651 to 2179 547 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
BG217306   .b 1655 to 2170 572 to 58     Submitted on the opposite strand 515/895
(57 %)
30 diff
(96.7 %id)
CB119419 Liver .b 1659 to 2179 561 to 41   AAA Submitted on the opposite strand 521/521
(100 %)
1 diff
(99.9 %id)
DB525635 testis .b 1662 to 2105 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
DB547548 hippocampus .b 1664 to 2105 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
DB546138 hippocampus .b 1671 to 2105 1 to 435     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
AA916220 Kidney .b 1672 to 1789 118 to 1       118/118
(100 %)
3 diff
(97.5 %id)
BU737508 eye, lens .b 1673 to 2176 517 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 502/502
(100 %)
0 diff
(100 %id)
DR761072 embryonic stem .b 1697 to 2174 520 to 43   AAA Submitted on the opposite strand 478/484
(98 %)
7 diff
(98.6 %id)
DB521516 testis .b 1704 to 2173 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
DB552678 hippocampus .b 1706 to 2179 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
DB575654 hypothalamus .b 1708 to 2178 1 to 471     Submitted on the opposite strand 471/472
(99 %)
1 diff
(99.8 %id)
DB541118 hippocampus .b 1709 to 2179 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AA707293   .b 1711 to 1906 202 to 7     Submitted on the opposite strand 196/202
(97 %)
3 diff
(98.6 %id)
FN107273 breast carcinoma .b 1714 to 1831 1 to 118       118/118
(100 %)
3 diff
(97.5 %id)
FN159053 breast carcinoma .b 1719 to 1835 119 to 1     Submitted on the opposite strand 119/119
(100 %)
4 diff
(96.7 %id)
DB551665 hippocampus .b 1719 to 2179 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
TI_149310214   .b 1719 to 2518 882 to 90   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 793/916
(86 %)
7 diff
(99.3 %id)
DB564837 hypothalamus .b 1721 to 2178 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
BU736726 eye, Retina Foveal and Macular .b 1721 to 2105 403 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BE182574 head_neck .b 1723 to 1959 235 to 2     Submitted on the opposite strand 234/235
(99 %)
2 diff
(99.2 %id)
CN370543 embryonic stem cells, DMSO-treated H9 cellline .b 1724 to 2179 478 to 23   AAA Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
DB521037 testis .b 1726 to 2179 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
DB529810 hippocampus .b 1728 to 2181 1 to 455     Submitted on the opposite strand 455/456
(99 %)
4 diff
(99.2 %id)
H86653 eye, retina .b 1728 to 2099 380 to 1     Submitted on the opposite strand 380/421
(90 %)
13 diff
(97.0 %id)
DB526417 testis .b 1729 to 2178 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
CN370545 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1737 to 1905 169 to 1     Submitted on the opposite strand 169/169
(100 %)
3 diff
(98.3 %id)
CR742202 alveolar rhabdomyosarcoma .b 1747 to 2179 444 to 12   AAA Submitted on the opposite strand 433/433
(100 %)
1 diff
(99.8 %id)
CB115974 Liver .b 1748 to 2179 456 to 25   AAA Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
AL578811 placenta .b 1758 to 2151 394 to 1   fully sequenced,   394/394
(100 %)
1 diff
(99.8 %id)
AA126255 uterus .b 1758 to 2105 372 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
AA190595   .b 1758 to 2168 434 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
BQ286655 Pancreas, Purified pancreatic islet .b 1758 to 2178 421 to 1   fully sequenced,   421/421
(100 %)
0 diff
(100 %id)
BU735330 eye, lens .b 1758 to 2105 366 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
DB555184 hypothalamus .b 1759 to 2178 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
BQ378986 uterus_tumor .b 1760 to 2018 263 to 5       259/268
(96 %)
0 diff
(100 %id)
AW749642 breast .b 1762 to 1921 161 to 2       160/164
(97 %)
2 diff
(98.8 %id)
CR742203 adenocarcinoma, Pancreas .b 1763 to 2142 439 to 55     Submitted on the opposite strand 385/439
(87 %)
0 diff
(100 %id)
BM150843 leukopheresis .b 1769 to 2178 427 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 410/411
(99 %)
0 diff
(100 %id)
AW969820   .b 1771 to 2105 426 to 92   AAA Submitted on the opposite strand 335/335
(100 %)
0 diff
(100 %id)
T19013   .b 1788 to 2184 400 to 2     Submitted on the opposite strand 399/405
(98 %)
6 diff
(98.6 %id)
BU688541 lung .b 1794 to 2518 742 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 724/724
(100 %)
1 diff
(99.9 %id)
AA149464 uterus .b 1798 to 2169 379 to 1     Submitted on the opposite strand 379/379
(100 %)
11 diff
(97.1 %id)
T19138   .b 1805 to 2179 382 to 1     Submitted on the opposite strand 382/405
(94 %)
13 diff
(96.8 %id)
BG216106   .b 1818 to 2136 325 to 8     Submitted on the opposite strand 318/325
(97 %)
0 diff
(100 %id)
FN122365 breast carcinoma .b 1818 to 1906 93 to 7     Submitted on the opposite strand 87/93
(93 %)
0 diff
(100 %id)
BG200017   .b 1823 to 2118 296 to 1     Submitted on the opposite strand 296/296
(100 %)
12 diff
(96.0 %id)
BQ372883 prostate_tumor .b 1827 to 1988 168 to 5       164/172
(95 %)
8 diff
(95.4 %id)
BG187096   .b 1832 to 2171 356 to 16     Submitted on the opposite strand 341/356
(95 %)
0 diff
(100 %id)
BG201389   .b 1841 to 2171 346 to 17     Submitted on the opposite strand 330/346
(95 %)
0 diff
(100 %id)
H00408 placenta .b 1841 to 2171 333 to 1     Submitted on the opposite strand 333/427
(77 %)
3 diff
(99.3 %id)
T19168   .b 1842 to 2148 307 to 1     Submitted on the opposite strand 307/307
(100 %)
3 diff
(99.1 %id)
AW749327 breast .b 1844 to 2056 226 to 14       213/244
(87 %)
0 diff
(100 %id)
AU156532 placenta .b 1851 to 2179 330 to 1       330/330
(100 %)
2 diff
(99.4 %id)
C75211   .b 1859 to 2175 318 to 2       317/318
(99 %)
0 diff
(100 %id)
AL555753 placenta .b 1872 to 2455 584 to 1   fully sequenced,   584/584
(100 %)
2 diff
(99.7 %id)
BG189792   .b 1874 to 2141 270 to 4     Submitted on the opposite strand 267/270
(98 %)
0 diff
(100 %id)
F03467 brain, total brain .b 1885 to 2179 295 to 1       295/295
(100 %)
0 diff
(100 %id)
FN053471 breast carcinoma .b 1888 to 1960 73 to 1     Submitted on the opposite strand 73/75
(97 %)
0 diff
(100 %id)
BG197912   .b 1890 to 2170 338 to 57     Submitted on the opposite strand 282/338
(83 %)
0 diff
(100 %id)
BG188686   .b 1892 to 2170 338 to 58   AAA Submitted on the opposite strand 281/324
(86 %)
0 diff
(100 %id)
BG213564   .b 1898 to 2171 289 to 16     Submitted on the opposite strand 274/290
(94 %)
0 diff
(100 %id)
F03702 brain, total brain .b 1898 to 2179 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AA058993 eye, retina .b 1898 to 2061 164 to 1     Submitted on the opposite strand 164/167
(98 %)
3 diff
(98.3 %id)
BG194763   .b 1910 to 2171 279 to 16     Submitted on the opposite strand 264/279
(94 %)
0 diff
(100 %id)
AA810360 Ewing's sarcoma .b 1927 to 2184 258 to 1       258/261
(98 %)
0 diff
(100 %id)
U54721 eye, lung adenocarcinoma .b 1931 to 2165 250 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 235/238
(98 %)
1 diff
(99.6 %id)
BG183937   .b 1956 to 2170 269 to 55     Submitted on the opposite strand 215/269
(79 %)
0 diff
(100 %id)
CN370556 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1962 to 2173 212 to 1     Submitted on the opposite strand 212/212
(100 %)
0 diff
(100 %id)
AA746619 pooled germ cell tumors .b 1965 to 2105 189 to 49   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 141/141
(100 %)
0 diff
(100 %id)
BG208315   .b 2003 to 2171 184 to 15     Submitted on the opposite strand 170/184
(92 %)
0 diff
(100 %id)
BG192848   .b 2004 to 2170 226 to 59     Submitted on the opposite strand 168/226
(74 %)
0 diff
(100 %id)
CN370533 embryonic stem cells, DMSO-treated H9 cellline .b 2070 to 2184 116 to 2     Submitted on the opposite strand 115/116
(99 %)
0 diff
(100 %id)
FN099770 breast carcinoma .b 2099 to 2209 1 to 112       112/123
(91 %)
2 diff
(98.4 %id)
AA088226 colon, tumor .b 2242 to 2482 243 to 3       241/243
(99 %)
0 diff
(100 %id)
AK315975 amygdala .c 1 to 2034 6 to 2039 exact tiling clone,   2039/2039
(100 %)
1 diff
(100.0 %id)
DC316578 amygdala .c 1 to 507 6 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BP226475   .d 1 to 578 6 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
AA112386   .d 17 to 371 1 to 358       358/365
(98 %)
9 diff
(97.6 %id)
DC425404   .d 47 to 597 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AK294665 brain .d 85 to 1703 1 to 1619 exact tiling clone,   1619/1619
(100 %)
0 diff
(100 %id)
DC319901 brain .d 85 to 647 1 to 563       563/563
(100 %)
0 diff
(100 %id)
AA151616 uterus .d 149 to 638 1 to 495     Submitted on the opposite strand 493/539
(91 %)
20 diff
(96.3 %id)
AA112387   .d 1418 to 1801 387 to 4   tiling clone,   384/387
(99 %)
1 diff
(99.8 %id)
TI_154168872   .e 1 to 617 80 to 587 V95L V96K I97S I98* tiling clone, Suspected internal deletion 511/511
(100 %)
0 diff
(100 %id)
BP327979 prostata .f 1 to 573 1 to 573   tiling clone,   573/573
(100 %)
6 diff
(99.0 %id)
CD653819 Embryonic Stem cells .f 226 to 1014 6 to 790 R164Q tiling clone,   785/843
(93 %)
20 diff
(97.7 %id)
T98684 liver and spleen .g 1 to 264 9 to 271   tiling clone, fully sequenced,   271/271
(100 %)
4 diff
(98.6 %id)
AA976271 Kidney, kidney tumor .g 76 to 508 430 to 1   tiling clone,   430/430
(100 %)
7 diff
(98.4 %id)
N35467 melanocyte .g 121 to 512 393 to 1     Submitted on the opposite strand 393/401
(98 %)
4 diff
(99.1 %id)
BG153416 carcinoid, lung .g 124 to 468 1 to 346     Submitted on the opposite strand 346/346
(100 %)
2 diff
(99.5 %id)
AI298793 carcinoid, lung .g 125 to 512 1 to 388     Submitted on the opposite strand 388/388
(100 %)
0 diff
(100 %id)
AA595173 breast .g 126 to 498 1 to 373     Submitted on the opposite strand 373/373
(100 %)
3 diff
(99.2 %id)
AW973549   .g 134 to 520 1 to 387   tiling clone, AAA   387/387
(100 %)
0 diff
(100 %id)
AI123533 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 143 to 496 1 to 354     Submitted on the opposite strand 354/354
(100 %)
0 diff
(100 %id)
N24676 melanocyte .g 147 to 504 1 to 360     Submitted on the opposite strand 360/360
(100 %)
2 diff
(99.5 %id)
AA577181 colon, colon tumor RER+ .g 147 to 468 1 to 320     Submitted on the opposite strand 320/320
(100 %)
2 diff
(99.4 %id)
AI298797 carcinoid, lung .g 147 to 490 1 to 344     Submitted on the opposite strand 344/344
(100 %)
0 diff
(100 %id)
AI400785 B-cell, chronic lymphotic leukemia .g 147 to 504 1 to 358     Submitted on the opposite strand 358/358
(100 %)
0 diff
(100 %id)
T98634 liver and spleen .g 234 to 497 268 to 1   fully sequenced,   268/268
(100 %)
5 diff
(98.2 %id)
BF438140 carcinoid, lung .h 1 to 422 1 to 423 L44S K45E Q46T M47N Q48A ... tiling clone, AAA Submitted on the opposite strand 423/423
(100 %)
5 diff
(98.9 %id)
AL706390 human skeletal muscle .i-u 1 to 595 1 to 600 Y25S I26V S27Y S28I L29S ... tiling clone,   600/600
(100 %)
9 diff
(98.5 %id)
DB197261 trachea .j-u 1 to 568 2 to 568 exact tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
CA439116 lung, Lung Focal Fibrosis .k 1 to 560 19 to 578 exact tiling clone, Submitted on the opposite strand 560/560
(100 %)
3 diff
(99.5 %id)
DB462312 testis .l-u 1 to 467 1 to 467 I3M S7G tiling clone,   467/467
(100 %)
3 diff
(99.4 %id)
AA490732 germinal center B cell .l-u 45 to 424 1 to 375       375/375
(100 %)
6 diff
(98.4 %id)
BE091876 breast .l-u 175 to 296 7 to 128       122/128
(95 %)
6 diff
(95.4 %id)
AI523283 aorta .m-u 1 to 451 453 to 1 exact tiling clone,   453/453
(100 %)
3 diff
(99.4 %id)
AI748931 aorta .m-u 149 to 451 303 to 1 exact     303/306
(99 %)
1 diff
(99.7 %id)
BF928565 nervous_tumor .o-u 1 to 159 1 to 156 K2* tiling clone,   156/156
(100 %)
9 diff
(94.3 %id)
AK295330 caudate nucleus Gene CCT4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AK307856 corpus callosum Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
AK308942 caudate nucleus Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC311044 alzheimer cortex Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC326494 caudate nucleus Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC327553 caudate nucleus Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC327745 caudate nucleus Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC328054 corpus callosum Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
ES313992 beard hair, skin Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
DC360835   Gene CCT4, variant not shown         This clone was ignored    
DC365897   Gene CCT4, variant not shown         This clone was ignored    
DC367950   Gene CCT4, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k, .l-u, .m-u, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI